The clinicopathological findings of the 27 patients with the initial results of ER−/PgR+ were as follows: the patients’ ages ranged from 39 to 73 years (mean age 55.8 years), and tumor size ranged from 0.1 to 11.7 cm (mean size 1.8 cm). The gene discussed is PGR; the disease is neoplasm.